Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 952.33 | 578 / 578 | 93% | 6.23 | 1074 / 1155 |
stomach | 89% | 265.74 | 319 / 359 | 90% | 4.90 | 258 / 286 |
pancreas | 78% | 129.55 | 257 / 328 | 88% | 4.71 | 157 / 178 |
breast | 76% | 164.36 | 351 / 459 | 86% | 3.95 | 966 / 1118 |
intestine | 74% | 469.51 | 714 / 966 | 88% | 3.58 | 462 / 527 |
esophagus | 56% | 97.24 | 811 / 1445 | 91% | 4.63 | 167 / 183 |
bladder | 62% | 143.19 | 13 / 21 | 63% | 2.52 | 320 / 504 |
thymus | 63% | 144.38 | 411 / 653 | 62% | 3.30 | 377 / 605 |
uterus | 51% | 70.99 | 86 / 170 | 72% | 3.93 | 330 / 459 |
skin | 60% | 216.89 | 1077 / 1809 | 62% | 3.46 | 293 / 472 |
prostate | 75% | 139.04 | 183 / 245 | 36% | 0.79 | 181 / 502 |
kidney | 37% | 83.53 | 33 / 89 | 73% | 2.87 | 658 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.63 | 29 / 29 |
peripheral blood | 100% | 2645.45 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 1574.71 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 93% | 267.16 | 1123 / 1204 | 0% | 0 | 0 / 0 |
ovary | 26% | 34.11 | 47 / 180 | 67% | 1.86 | 287 / 430 |
tonsil | 0% | 0 | 0 / 0 | 87% | 4.77 | 39 / 45 |
adrenal gland | 71% | 108.60 | 184 / 258 | 14% | 0.37 | 32 / 230 |
liver | 51% | 72.12 | 115 / 226 | 26% | 0.70 | 107 / 406 |
blood vessel | 74% | 165.98 | 984 / 1335 | 0% | 0 | 0 / 0 |
brain | 11% | 13.97 | 282 / 2642 | 23% | 0.54 | 162 / 705 |
heart | 24% | 35.64 | 206 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 9% | 0.22 | 7 / 80 |
muscle | 2% | 2.40 | 16 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_1901222 | Biological process | regulation of non-canonical NF-kappaB signal transduction |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0070433 | Biological process | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_1902523 | Biological process | positive regulation of protein K63-linked ubiquitination |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0043508 | Biological process | negative regulation of JUN kinase activity |
GO_0045088 | Biological process | regulation of innate immune response |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0030217 | Biological process | T cell differentiation |
GO_0034145 | Biological process | positive regulation of toll-like receptor 4 signaling pathway |
GO_0050855 | Biological process | regulation of B cell receptor signaling pathway |
GO_0032717 | Biological process | negative regulation of interleukin-8 production |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0006914 | Biological process | autophagy |
GO_0032817 | Biological process | regulation of natural killer cell proliferation |
GO_0035644 | Biological process | phosphoanandamide dephosphorylation |
GO_0071225 | Biological process | cellular response to muramyl dipeptide |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0006629 | Biological process | lipid metabolic process |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0034141 | Biological process | positive regulation of toll-like receptor 3 signaling pathway |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_1903753 | Biological process | negative regulation of p38MAPK cascade |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004726 | Molecular function | non-membrane spanning protein tyrosine phosphatase activity |
GO_0019900 | Molecular function | kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0016791 | Molecular function | phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPN22 |
Protein name | Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP) protein-tyrosine-phosphatase (EC 3.1.3.48) Protein tyrosine phosphatase non-receptor type 22 |
Synonyms | PTPN8 |
Description | FUNCTION: Acts as a negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules . Associates with and probably dephosphorylates CBL. Dephosphorylates LCK at its activating 'Tyr-394' residue . Dephosphorylates ZAP70 at its activating 'Tyr-493' residue . Dephosphorylates the immune system activator SKAP2 . Positively regulates toll-like receptor (TLR)-induced type 1 interferon production . Promotes host antiviral responses mediated by type 1 interferon (By similarity). Regulates NOD2-induced pro-inflammatory cytokine secretion and autophagy . Acts as an activator of NLRP3 inflammasome assembly by mediating dephosphorylation of 'Tyr-861' of NLRP3 . Dephosphorylates phospho-anandamide (p-AEA), an endocannabinoid to anandamide (also called N-arachidonoylethanolamide) (By similarity). . |
Accessions | F5H2S8 ENST00000525799.1 ENST00000532224.5 ENST00000460620.5 [Q9Y2R2-5] A0A0B4J1S7 ENST00000538253.5 ENST00000529045.1 E9PM87 A0A0A0MTD9 E9PMT0 ENST00000359785.10 Q9Y2R2 E9PMK2 A0A0A0MTE6 A0A1S6KJG4 ENST00000528414.5 ENST00000420377.6 G3K0T4 |